首页> 外文OA文献 >Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models

【2h】

Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models

机译：双特异性抗体在两个白血病复发模型中靶向可操作的肿瘤特异性抗原

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
H Lindhofer; H Menzel; W Gunther; L Hultner; S Thierfelder;
展开▼
作者单位

展开▼
年度 1996
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Quantitative Systems Pharmacology Modeling to Evaluate and Prioritize Targets (CD19, CD20, CD22) for Bispecific Antibodies and CAR-T in Acute Lymphoblastic Leukemia [J] . Demin Oleg Jr., Nikitich Antonina Journal of pharmacokinetics and pharmacodynamics . 2017,第Suppla期

机译：急性淋巴细胞白血病中双特异性抗体和CAR-T评估和优先考虑靶标（CD19，CD20，CD22）的定量系统药理学建模
2. A Bispecific Molecule Targeting CD40 and Tumor Antigen Mesothelin Enhances Tumor-Specific Immunity [J] . Shiming Ye, Diane Cohen, Nicole A. Belmar, Cancer immunology research. . 2019,第11期

机译：靶向CD40和肿瘤抗原间素的双特分子提高了肿瘤特异性免疫力
3. Efficacy and safety of bispecific T-cell engager (BiTE) antibody blinatumomab for the treatment of relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin's lymphoma: a systemic review and meta-analysis [J] . Yu Jian, Wang Wen, Huang He Hematology. . 2019,第1期

机译：双特异性T细胞参录（咬合）抗体Blinatumab用于治疗复发/难治性急性淋巴细胞白血病和非霍奇金淋巴瘤的疗效和安全性：全身评测和荟萃分析
4. HPMA Copolymer-Bound Doxorubicin Targeted with Monoclonal Antibody to Tumor-Specific Antigen of BCL1 Leukemia Cells Can Completely Cure Tumor-Bearing Mice and Establish Long- Term Immunological Memory to the Original Tumor [C] . Controlled Release Society annual meeting . 2004

机译：靶向具有BCL1白血病细胞的肿瘤特异性抗原的单克隆抗体的HPMA共聚的多柔比蛋白可以完全固化携带肿瘤的小鼠并对原始肿瘤建立长期免疫记忆
5. Antigen targeting and drug delivery employing bifunctional fusion protein and bispecific antibodies. [D] . Wang, Welson Wen Shang. 2008

机译：使用双功能融合蛋白和双特异性抗体进行抗原靶向和药物递送。
6. A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia [O] . Yiyun Wang, Yingying Yang, Ruimin Hong, 2020

机译：复发/难治性急性淋巴细胞白血病患者CD19单型和CD19 / CD22双特异性嵌合抗原受体T细胞治疗的回顾性比较
7. Preclinical Assessment of AMG 596, a Bispecific T-cell Engager (BiTE) Immunotherapy Targeting the Tumor-specific Antigen EGFRvIII [O] . Alexander Sternjak, Fei Lee, Oliver Thomas, 2021

机译：AMG 596的临床前评估，一种靶向肿瘤特异性抗原EGFRVIII的双特异性T细胞参录（BITE）免疫疗法
8. Cell Penetrating Bispecific Antibodies for Targeting Oncogenic Transcription Factors in Advanced Prostate Cancer. [R] . Lilly, M., Weisbart, R. 2016

机译：细胞穿透双特异性抗体靶向晚期前列腺癌的致癌转录因子。

Bispecific antibodies target operationally tumor-specific antigens in two leukemia relapse models

著录项

引文网络

相似文献

相关主题

期刊订阅